title: CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1 alpha, interleukin-8 and RANTES.
abstract: The chemokines macrophage inflammatory protein 1 alpha (MIP 1 alpha), interleukin-8 (IL-8) and RANTES are potent regulators of leukocyte trafficking. Examination of chemokine secretion by human peripheral blood lymphocytes after stimulation with anti-CD3 or phorbol 12, 13 myristate acetate and ionomycin showed CD8+ cells were the dominant source of MIP 1 alpha and RANTES. Although production of MIP 1 alpha and IL-8 were similar in pharmacologically stimulated CD4+ CD45RA+, CD4+ CD45RO+, and CD8+ CD45RA+ cells, the largest amounts of MIP 1 alpha and RANTES were secreted by CD8+ CD45RO+ lymphocytes. A parallel pattern of prolonged chemokine mRNA expression for at least 18 h after activation was observed in the T cells subsets. These results confirm that human T lymphocytes have a unique capacity for secretion of these three chemokines. In addition, CD8+ cells have an unrecognized role in recruiting cells to sites of inflammation, and adult human CD45RA+ cells have a physiologically significant secretory capacity.
authors.affiliation: Laboratory of Experimental Immunology, NCI-FCRDC, MD 21702-1201, USA.
authors.forename: K
authors.initials: K
authors.lastname: Conlon
authors.forename: A
authors.initials: A
authors.lastname: Lloyd
authors.forename: U
authors.initials: U
authors.lastname: Chattopadhyay
authors.forename: N
authors.initials: N
authors.lastname: Lukacs
authors.forename: S
authors.initials: S
authors.lastname: Kunkel
authors.forename: T
authors.initials: T
authors.lastname: Schall
authors.forename: D
authors.initials: D
authors.lastname: Taub
authors.forename: C
authors.initials: C
authors.lastname: Morimoto
authors.forename: J
authors.initials: J
authors.lastname: Osborne
authors.forename: J
authors.initials: J
authors.lastname: Oppenheim
mesh_terms: D015152:Blotting, Northern; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D018946:Chemokine CCL5; D016207:Cytokines / Q000096:biosynthesis*; D005434:Flow Cytometry; D006801:Humans; D016209:Interleukin-8 / Q000096:biosynthesis; D017493:Leukocyte Common Antigens / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D008222:Lymphokines / Q000096:biosynthesis; D019402:Macrophage Inflammatory Proteins; D015846:Monokines / Q000096:biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis; D016176:T-Lymphocyte Subsets / Q000276:immunology*
chemical_list: D054405:Chemokine CCL3; D054407:Chemokine CCL4; D018946:Chemokine CCL5; D016207:Cytokines; D016209:Interleukin-8; D008222:Lymphokines; D019402:Macrophage Inflammatory Proteins; D015846:Monokines; D012333:RNA, Messenger; D017493:Leukocyte Common Antigens